New Enterprise Associates

Johnson & Johnson

Sep 20, 2018

Epic Sciences garners; Tvardi gets financing; Galera raises; Fund for cancer research

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper